Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barnett

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Journal of Comparative Pathology|May 27, 2023
The first report of meningitis in a Greenland shark (Somniosus microcephalus)James E F Barnett, Ladislav Novotny, Kelly Astley, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitorsZhijian Zhao, William H Leister, Ronald G Robinson, et al.
European Heart Journal. Acute Cardiovascular Care|July 4, 2026
Hyperoxia reflects poor native cardiac function and demonstrates cardiac index-dependent associations with mortality in VA-ECMO patientsRyan K Ruaysungnoen, Anja Strehlow, Sylvie Baudart, et al.
Diseases of Aquatic Organisms|February 12, 2026
Traumatic injuries by grey seals on delphinids from northwest European watersLonneke L IJsseldijk, James E F Barnett, Rob Deaville, et al.
The Biochemical Journal|January 27, 2011
Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escapeRené Bartz, Haihong Fan, Jingtao Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
Development of pyridopyrimidines as potent Akt1/2 inhibitorsZhicai Wu, John C Hartnett, Lou Anne Neilson, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
Allosteric inhibitors of Akt1 and Akt2: discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activityYiwei Li, Jun Liang, Tony Siu, et al.
Regulatory Toxicology and Pharmacology : RTP|August 18, 2009
Safety assessment of a modified acetolactate synthase protein (GM-HRA) used as a selectable marker in genetically modified soybeansC A Mathesius, J F Barnett, R F Cressman, et al.
The Veterinary Record|September 28, 2010
Assessment of antemortem tests used in the control of an outbreak of tuberculosis in llamas (Lama glama)D F Twomey, T R Crawshaw, J E Anscombe, et al.
Molecular Cancer Therapeutics|February 17, 2005
Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family membersDeborah DeFeo-Jones, Stanley F Barnett, Sheng Fu, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Journal of Comparative Pathology|May 27, 2023
The first report of meningitis in a Greenland shark (Somniosus microcephalus)James E F Barnett, Ladislav Novotny, Kelly Astley, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitorsZhijian Zhao, William H Leister, Ronald G Robinson, et al.
European Heart Journal. Acute Cardiovascular Care|July 4, 2026
Hyperoxia reflects poor native cardiac function and demonstrates cardiac index-dependent associations with mortality in VA-ECMO patientsRyan K Ruaysungnoen, Anja Strehlow, Sylvie Baudart, et al.
Diseases of Aquatic Organisms|February 12, 2026
Traumatic injuries by grey seals on delphinids from northwest European watersLonneke L IJsseldijk, James E F Barnett, Rob Deaville, et al.
The Biochemical Journal|January 27, 2011
Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escapeRené Bartz, Haihong Fan, Jingtao Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
Development of pyridopyrimidines as potent Akt1/2 inhibitorsZhicai Wu, John C Hartnett, Lou Anne Neilson, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
Allosteric inhibitors of Akt1 and Akt2: discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activityYiwei Li, Jun Liang, Tony Siu, et al.
Regulatory Toxicology and Pharmacology : RTP|August 18, 2009
Safety assessment of a modified acetolactate synthase protein (GM-HRA) used as a selectable marker in genetically modified soybeansC A Mathesius, J F Barnett, R F Cressman, et al.
The Veterinary Record|September 28, 2010
Assessment of antemortem tests used in the control of an outbreak of tuberculosis in llamas (Lama glama)D F Twomey, T R Crawshaw, J E Anscombe, et al.
Molecular Cancer Therapeutics|February 17, 2005
Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family membersDeborah DeFeo-Jones, Stanley F Barnett, Sheng Fu, et al.
Pageof 19